Bursitis and Agranulocytosis

Summary:

Agranulocytosis is found among people with Bursitis, especially for people who are male, 40-49 old.

The study analyzes which people have Agranulocytosis with Bursitis. It is created by eHealthMe based on reports of 17 people who have Bursitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Bursitis?

Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder) is found to be associated with 1,173 drugs and 1,049 conditions by eHealthMe. Check the latest studies of Bursitis.

What is Agranulocytosis?

Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection) is found to be associated with 2,327 drugs and 3,591 conditions by eHealthMe. Check the latest studies of Agranulocytosis.

On Jul, 06, 2026

17 people who have Bursitis and Agranulocytosis are studied.

Would you have Agranulocytosis when you have Bursitis?

Gender of people who have Bursitis and experienced Agranulocytosis *:

female: 29.41 %
male: 70.59 %

Age of people who have Bursitis and experienced Agranulocytosis *:

Common co-existing conditions for these people *:

Pain: 7 people, 41.18%
Multiple Myeloma (cancer of the plasma cells): 5 people, 29.41%
Fever: 4 people, 23.53%
Bone Disorder: 2 people, 11.76%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 1 person, 5.88%
Indigestion: 1 person, 5.88%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 1 person, 5.88%
High Blood Pressure: 1 person, 5.88%
General Anaesthesia: 1 person, 5.88%

Common drugs taken by these people *:

Common symptoms for these people *:

Rashes (redness): 11 people, 64.71%
Drug Rash With Eosinophilia And Systemic Symptoms (adverse drug reactions with rash): 9 people, 52.94%
Liver Injury: 9 people, 52.94%
Limb Discomfort (discomfort in leg): 5 people, 29.41%
Neuropathy Peripheral (surface nerve damage): 5 people, 29.41%
Joint Pain: 5 people, 29.41%
Gingival Bleeding (bleeding gums): 5 people, 29.41%
Eye Infection Viral: 5 people, 29.41%
Eye Infection: 5 people, 29.41%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Agranulocytosis?

- Check whether Agranulocytosis is associated with a drug or a condition

Related publications that referenced our studies

Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .
Fasullo, S., Davì, S., Cosenza, G., Di Franco, F., La Manna, N., Giubilato, A., ... & Maringhini, G. , "Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature", Journal of thrombosis and thrombolysis, 2018 Jan .

Related studies:

Treatments, associated drugs and conditions:

Bursitis (18,537 reports)
Agranulocytosis (213,267 reports)

All the drugs that are associated with Agranulocytosis:

Agranulocytosis (2,327 drugs)

All the conditions that are associated with Agranulocytosis:

Agranulocytosis (3,591 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Agranulocytosis and Bursitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.